Efficacy and Safety of Finerenone vs. Spironolactone in Patients With Primary Aldosteronism

NCT06164379 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Primary Aldosteronism

Interventions

DRUG: Finerenone
DRUG: Spironolactone

Sponsor

Shanghai Jiao Tong University School of Medicine